Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction

Free Radical Research

Volumn 39, Issue 6, 2005, Pages 629-636

  Berg, Kirsti ^a   Jynge, Per ^a   Bjerve, Kristian ^b   Skarra, Sissel ^a   Basu, Samar ^c   Wiseth, Rune ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inflammation; Isoprostanes; Myocardial infarction; Oxidative stress; PCI

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; FEMALE; FREQUENCY ANALYSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; INFLAMMATION; MALE; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ADULT; AGED; CORONARY VESSELS; DINOPROST; FEMALE; HUMANS; HYDROXYLATION; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; SERUM ALBUMIN; TROPONIN T;

EID: 20544436172     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760400028027     Document Type: Article

References (47)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
2. Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: Rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 2003;146:234-241.
3. van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
4. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J Am Coll Cardiol 2004;44:276-286.
5. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-2306.
6. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
7. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;47:446-456.
8. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
9. Dirksen MT, Laarman G, van't Hof AW, Guagliumi G, Tonino WA, Tavazzi L, Duncker DJ, Simoons ML. The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty; Safety and efficacy of a novel tetrapeptide, ITF-1697. Eur Heart J 2004;68:392-400.
10. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997;95:2492-2499.
11. Guan W, Osanai T, Kamada T, Ishizaka H, Hanada H, Okumura K. Time course of free radical production after primary coronary angioplasty for acute myocardial infarction and the effect of vitamin C. Jpn Circ J 1999;63:924-928.
12. Iuliano L, Pratico D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, Violi F. Angioplasty increases coronary sinus F2-isoprostane formation: Evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001;37:76-80.
13. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1. Circulation 2001;104:2981-2989.
14. Lafont A, Marwick TH, Chisholm GM, Van Lente F, Vaska KJ, Whitlow PL. Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 1996;131:219-223.
15. Meydani M, Mayer J. Isoprostanes as oxidant stress markers in coronary reperfusion. Nutr Rev 1997;55:404-407.
16. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans. Circulation 1997;96:3314-3320.
17. Olsson KA, Harnek J, Ohlin AK, Pavlidis N, Thorvinger B, Ohlin H. No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction. Scand Cardiovasc J 2002;36:237-240.
18. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP, Condorelli M, Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991;87:2056-2066.
19. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 1999; 13:977-994.
20. Sodergren E, Cederberg J, Basu S, Vessby B. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats. J Nutt 2000;130:10-14.
21. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-455.
22. Gopaul NK, Halliwell B, Anggard EE. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radic Res 2000;33:115-127.
23. Pryor WA. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-164.
24. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts 2, LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-9387.
25. Morrow JD, Roberts LJ. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1-21.
26. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury. Int J Cardiol 2002;86:41-59.
27. Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998;58:347-352.
28. Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998;438:159-160.
29. Basu S. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 2000;468:33-36.
30. Mutschler DK, Eriksson MB, Wikstrom BG, Lind L, Larsson A, Bergren-Kiiski R, Lagrange A, Nordgren A, Basu S. Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 2003;31:1780-1785.
31. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: An index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 1998;58:319-325.
32. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, Jynge P, Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004;38:517-525.
33. vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997;29:2571-2583.
34. Kevin LG, Camara AK, Riess ML, Novalija E, Stowe DF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003;284:H566-H574.
35. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-470.
36. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: An overview. Basic Res Cardiol 1996;91:57-63.
37. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-983.
38. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-H827.
39. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
40. Fields M, Lewis CG, Bureau I. Aspirin reduces blood cholesterol in copper-deficient rats: A potential antioxidant agent? Metabolism 2001;50:558-561.
41. Powell SR. Salicylate trapping of OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. Free Radic Res 1994;21:355-370.
42. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003;110:255-258.
43. Helmersson J, Vessby B, Larsson A, Basu S. Cyclooxygenase-mediated prostaglandin F2a is decreased in an elderly population treated with low-dose aspirin. Prostaglandins Leuk and Essential Fatty Acids 2004 (in press).
44. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902-912.
45. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus HA. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-150.
46. Kawakami T, Lowbeer C, Valen G, Vaage J. Post-ischaemic dysfunction does not correlate with release of cardiac troponin T in isolated rat hearts. Acta Physiol Scand 1999;167:23-27.
47. Das DK, Maulik N. Conversion of death signal into survival signal by redox signaling. Biochemistry Mosc 2004;69:10-17.